JP2016531895A5 - - Google Patents

Download PDF

Info

Publication number
JP2016531895A5
JP2016531895A5 JP2016520004A JP2016520004A JP2016531895A5 JP 2016531895 A5 JP2016531895 A5 JP 2016531895A5 JP 2016520004 A JP2016520004 A JP 2016520004A JP 2016520004 A JP2016520004 A JP 2016520004A JP 2016531895 A5 JP2016531895 A5 JP 2016531895A5
Authority
JP
Japan
Prior art keywords
conjugate
conjugate according
patient
polyethylene glycol
peg
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2016520004A
Other languages
English (en)
Japanese (ja)
Other versions
JP2016531895A (ja
JP6473145B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2014/059146 external-priority patent/WO2015051307A1/en
Publication of JP2016531895A publication Critical patent/JP2016531895A/ja
Publication of JP2016531895A5 publication Critical patent/JP2016531895A5/ja
Application granted granted Critical
Publication of JP6473145B2 publication Critical patent/JP6473145B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2016520004A 2013-10-04 2014-10-03 Sn−38の徐放性コンジュゲート Active JP6473145B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201361887111P 2013-10-04 2013-10-04
US61/887,111 2013-10-04
PCT/US2014/059146 WO2015051307A1 (en) 2013-10-04 2014-10-03 Slow-release conjugates of sn-38

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2019010029A Division JP6842479B2 (ja) 2013-10-04 2019-01-24 Sn−38の徐放性コンジュゲート

Publications (3)

Publication Number Publication Date
JP2016531895A JP2016531895A (ja) 2016-10-13
JP2016531895A5 true JP2016531895A5 (enExample) 2017-11-09
JP6473145B2 JP6473145B2 (ja) 2019-02-20

Family

ID=51871275

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2016520004A Active JP6473145B2 (ja) 2013-10-04 2014-10-03 Sn−38の徐放性コンジュゲート
JP2019010029A Active JP6842479B2 (ja) 2013-10-04 2019-01-24 Sn−38の徐放性コンジュゲート

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2019010029A Active JP6842479B2 (ja) 2013-10-04 2019-01-24 Sn−38の徐放性コンジュゲート

Country Status (14)

Country Link
US (2) US10016411B2 (enExample)
EP (1) EP3052101B1 (enExample)
JP (2) JP6473145B2 (enExample)
KR (1) KR102320753B1 (enExample)
CN (1) CN106061483B (enExample)
AU (2) AU2014331591B2 (enExample)
BR (1) BR112016007410B1 (enExample)
CA (1) CA2925132C (enExample)
DK (1) DK3052101T3 (enExample)
ES (1) ES2759905T3 (enExample)
MX (1) MX371201B (enExample)
SG (2) SG11201602258WA (enExample)
TW (1) TWI716342B (enExample)
WO (1) WO2015051307A1 (enExample)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6473145B2 (ja) * 2013-10-04 2019-02-20 プロリンクス エルエルシー Sn−38の徐放性コンジュゲート
CN107375288B (zh) * 2016-05-16 2019-08-23 博瑞生物医药(苏州)股份有限公司 多臂的聚合靶向抗癌偶联物
ES2859473T3 (es) * 2017-04-21 2021-10-04 Bright Gene Bio Medical Tech Co Ltd Conjugado anticanceroso dirigido de múltiples brazos
RU2020126774A (ru) * 2018-01-12 2022-02-14 ПРОЛИНКС ЭлЭлСи Протокол для сведения к минимуму токсического воздействия комбинированных доз и визуализирующий агент для подтверждения
JP7546552B2 (ja) 2018-09-17 2024-09-06 ザ・チルドレンズ・ホスピタル・オブ・フィラデルフィア ポリマーベースの高分子プロドラッグ
KR20210150496A (ko) 2019-04-05 2021-12-10 프로린크스 엘엘시 개선된 컨쥬게이션 링커
MX2022002340A (es) 2019-08-28 2022-04-06 Prolynx Llc Inhibidores conjugados de la respuesta al daño de adn.
AU2021347611A1 (en) 2020-09-28 2023-05-18 Fundació Institut De Recerca Biomèdica (Irb Barcelona) Peptidic conjugates of sn38 useful in the treatment of cancer
US11976196B2 (en) * 2021-04-14 2024-05-07 Cambridge Crops, Inc. Silk packaging applications
JP2025512809A (ja) 2022-03-28 2025-04-22 ホスピタル サン ジョアン デ デウ 抗がん剤のペプチド性水溶性送達システム

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6011042A (en) * 1997-10-10 2000-01-04 Enzon, Inc. Acyl polymeric derivatives of aromatic hydroxyl-containing compounds
WO2004008101A2 (en) * 2002-07-12 2004-01-22 Biomarin Pharmaceutical Inc. The use of isocyanate linkers to make hydrolyzable active agent biopolymer conjugates
CN1309763C (zh) 2002-10-31 2007-04-11 日本化药株式会社 喜树碱的高分子衍生物
US20040247624A1 (en) * 2003-06-05 2004-12-09 Unger Evan Charles Methods of making pharmaceutical formulations for the delivery of drugs having low aqueous solubility
SI1675622T1 (sl) * 2003-09-17 2017-09-29 Nektar Therapeutics Večkraka polimerna predzdravila
US7462627B2 (en) 2006-02-09 2008-12-09 Enzon Pharmaceuticals, Inc. Multi-arm polymeric conjugates of 7-ethyl-10-hydroxycamptothecin for treatment of breast, colorectal, pancreatic, ovarian and lung cancers
RU2009114154A (ru) * 2006-09-15 2010-10-20 Энзон Фармасьютикалз, Инк. (Us) Полимерные пролекарства с направленной доставкой, содержащие полифункциональные линкеры
CA2738807A1 (en) * 2008-10-21 2010-04-29 Enzon Pharmaceuticals, Inc. Treatment of neuroblastoma with multi-arm polymeric conjugates of 7-ethyl-10-hydroxycamptothecin
JP2012509469A (ja) 2008-11-18 2012-04-19 バクスター・インターナショナル・インコーポレイテッド ポリエチレングリコールサンプルの多分散度および/または分子量分布を決定する方法
JP2012528240A (ja) 2009-05-28 2012-11-12 メルサナ セラピューティックス, インコーポレイテッド 可変速度放出リンカーを含むポリアル−薬物コンジュゲート
EA024533B1 (ru) * 2009-11-18 2016-09-30 Нектар Терапьютикс Формы солей кислот конъюгатов полимер-лекарственное средство
EP2571496A4 (en) * 2010-05-05 2016-03-30 Prolynx Llc CONTROLLED RELEASE OF MEDICINE FROM DENIMERS
US8754190B2 (en) 2010-05-05 2014-06-17 Prolynx Llc Controlled release from macromolecular conjugates
JP2012000072A (ja) * 2010-06-18 2012-01-05 Japan Health Science Foundation 新規な抗フィブリン抗体
TW201215412A (en) * 2010-08-30 2012-04-16 Sun Pharma Advanced Res Co Ltd Stable pharmaceutical composition
JP5899241B2 (ja) * 2010-12-21 2016-04-06 ネクター セラピューティクス ペメトレキセドベースの化合物のマルチアームポリマープロドラッグコンジュゲート
WO2013036857A1 (en) * 2011-09-07 2013-03-14 Prolynx Llc Sulfone linkers
JP6473145B2 (ja) * 2013-10-04 2019-02-20 プロリンクス エルエルシー Sn−38の徐放性コンジュゲート

Similar Documents

Publication Publication Date Title
JP2016531895A5 (enExample)
JP2018528184A5 (enExample)
JP2013519645A5 (enExample)
JP2013542247A5 (enExample)
SG11201908101YA (en) Hepatitis b virus surface antigen inhibitor
ES2365988T3 (es) Agentes inmunoestimulantes no específicos.
HRP20141258T1 (hr) 6-amino-2-{[(1s)-1-metilbutil]oksi}-9-[5-(1-piperidinil)pentil]-7,9-dihidro-8h-purin-8-on maleat
JP2013510120A5 (enExample)
RU2018105655A (ru) Комбинированная терапия с применением липосомального иринотекана и ингибитора parp для лечения рака
HRP20170433T1 (hr) Pripravci spoja za izmjenu lipidiranog imunološkog odgovora, formulacije, i postupci
JP2016506916A5 (enExample)
JP2015505296A5 (enExample)
JP2013510123A5 (enExample)
RU2013121788A (ru) Ингибиторы репликации вич
JP2010270124A5 (enExample)
JP2015532295A5 (enExample)
WO2009095226A3 (en) NUCLEIC ACIDS COMPRISING FORMULA (NuGlXmGnNv)a AND DERIVATIVES THEREOF AS AN IMMUNOSTIMULATING AGENTS /ADJUVANTS
JP2017525718A5 (enExample)
JP2016516074A5 (enExample)
RU2017112308A (ru) Композиции и способы для лечения бессонницы
RU2013104401A (ru) Фармацевтический препарат, содержащий ингибитор фосфодиэстеразы
JP2019515908A5 (enExample)
RU2017134443A (ru) Способ лечения с применением традипитанта
JP2017513809A5 (enExample)
JP2012503602A5 (enExample)